What the Latest NEJM Review Gets Right, and Glosses Over A Critique and Summary of the GLP-1 Receptor Agonists Review by Clifford J. Rosen and Julie R. Ingelfinger, published in NEJM ON April 2, 2026. The New England Journal of Medicine just published a sweeping review of GLP-1 receptor agonists, the class of drugs behindContinueContinue reading “The Ozempic Era Grows Up”
Tag Archives: wegovy
Update: New Options for Weight Loss
Orforglipron|Wegovy|Retatrutide The landscape of metabolic medicine is shifting beneath our feet. For the last few years, the conversation has been dominated by weekly injections like Zepbound (tirzepatide) and Wegovy (semaglutide). But as we move through 2026, the “second generation” of obesity treatments has arrived, offering more convenience and, in some cases, power that rivals bariatricContinueContinue reading “Update: New Options for Weight Loss”
Dr Bob, Brain Mechanic 